Skip to main content

Advertisement

Log in

Efficacy and safety of radiofrequency ablation and laparoscopic adrenalectomy for primary aldosteronism: a meta‑analysis

  • Special Section: Endometriosis and Adenomyosis
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Objective

To compare the efficacy (including blood pressure, medication reduction, serum potassium, and clinical success) and safety parameters (including operative time, length of hospital stay, blood loss, hypertension crisis rate, and complication rate) of radiofrequency ablation (RFA) and laparoscopic adrenalectomy (LA) in the treatment of primary aldosteronism (PA).

Methods

Literature search was performed on PubMed, EMBASE, The Cochrane Library (Issue 8, 2023), Web of Science, China National Knowledge Infrastructure, and Wanfang from inception to August 2023. Study selection, data extraction, and risk of bias assessment were performed by two independent reviewers. Quality assessment was conducted using the Newcastle–Ottawa scale. The Stata 12.0 software was used for statistical analyses. Pooled odds ratios (OR) with corresponding 95% confidence interval (CI) were calculated for categorical outcomes, while mean difference (MD) with corresponding 95% CI were calculated for continuous outcomes.

Results

A total of 5 studies involving 204 patients (LA, n = 127; and RAF, n = 77) were included. LA had better diastolic blood pressure control than RFA (WMD = 5.19; 95% CI 0.96–9.43); however, the RFA demonstrated better shorter operative time (WMD = − 57.99; 95% CI − 116.54 to 0.57), and shorter length of hospital stay (OR − 1.6; 95% CI − 2.37 to − 0.83) compared to LA. All remaining parameters were comparable between the interventions.

Conclusion

While grossly comparable in efficacy as treatment options for PA, RFA may allow for shorter operative time and hospital stay, less intraoperative blood loss, and lower hospitalization costs. However, LA has better diastolic blood pressure control. Even so, we still need larger prospective studies, specifically with comparative hypertension response (short and long term) and number of post-procedural antihypertensive medication requirement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Auchus RJ. Approaching primary aldosteronism as a common disease. Endocr Pract. 2023.

    Article  PubMed  Google Scholar 

  2. Sudano I, Suter P, Beuschlein F. Secondary hypertension as a cause of treatment resistance. Blood Press. 2023;32(1):2224898.

    Article  PubMed  Google Scholar 

  3. Nezu K, Kawasaki Y, Morimoto R, Ono Y, Omata K, Tezuka Y, et al. Impact of Adrenalectomy on Diastolic Cardiac Dysfunction in Patients with Primary Aldosteronism. Tohoku J Exp Med. 2023;259(3):229-36.

    Article  PubMed  Google Scholar 

  4. Buffolo F, Tetti M, Mulatero P, Monticone S. Aldosterone as a Mediator of Cardiovascular Damage. Hypertension. 2022;79(9):1899-911.

    Article  CAS  PubMed  Google Scholar 

  5. Aune A, Gerdts E, Kokorina M, Kringeland E, Midtbø H, Løvås K, et al. Persistent cardiac organ damage in surgically and medically treated primary aldosteronism. J Hypertens. 2022;40(6):1204-11.

    Article  CAS  PubMed  Google Scholar 

  6. Otsuka H, Abe M, Kobayashi H. The Effect of Aldosterone on Cardiorenal and Metabolic Systems. Int J Mol Sci. 2023;24(6).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Calhoun DA. Is there an unrecognized epidemic of primary aldosteronism? Pro. Hypertension. 2007;50(3):447-53; discussion -53.

    Article  CAS  PubMed  Google Scholar 

  8. Libianto R, Stowasser M, Russell G, Fuller PJ, Yang J. Improving Detection Rates for Primary Aldosteronism. Exp Clin Endocrinol Diabetes. 2023;131(7-08):402-8.

    PubMed  Google Scholar 

  9. Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41-50.

    Article  CAS  PubMed  Google Scholar 

  10. Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, et al. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr Pathol. 2022;33(1):155-96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Young WF, Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019;285(2):126-48.

    Article  PubMed  Google Scholar 

  12. Katsuragawa S, Goto A, Shinoda S, Inoue K, Nakai K, Saito J, et al. Association of Reversal of Renin Suppression With Long-Term Renal Outcome in Medically Treated Primary Aldosteronism. Hypertension. 2023;80(9):1909-20.

    Article  CAS  PubMed  Google Scholar 

  13. Zhou Y, Wang X, Hou J, Wan J, Yang Y, Liu S, et al. A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism. Hypertens Res. 2023.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mullen N, Curneen J, Donlon PT, Prakash P, Bancos I, Gurnell M, et al. Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks. Endocr Rev. 2023.

    Article  PubMed Central  Google Scholar 

  15. Picado O, Whitfield BW, Khan ZF, Jeraq M, Farrá JC, Lew JI. Long-term outcome success after operative treatment for primary aldosteronism. Surgery. 2021;169(3):528-32.

    Article  PubMed  Google Scholar 

  16. Pang TC, Bambach C, Monaghan JC, Sidhu SB, Bune A, Delbridge LW, et al. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. ANZ J Surg. 2007;77(9):768-73.

    Article  PubMed  Google Scholar 

  17. Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab. 2009;94(7):2437-45.

    Article  CAS  PubMed  Google Scholar 

  18. Tang F, Loh LM, Foo RS, Loh WJ, Lim DST, Zhang M, et al. Tolerability and Efficacy of Long-Term Medical Therapy in Primary Aldosteronism. J Endocr Soc. 2021;5(11):bvab144.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Patel V, Lindquester WS, Dhangana R, Medsinge A. Percutaneous ablation of renal tumors versus surgical ablation and partial nephrectomy: Medicare trends and reimbursement cost comparison from 2010 to 2018. Abdom Radiol (NY). 2022;47(2):885-90.

    Article  Google Scholar 

  20. Fu R, Ling W. The current role of radiofrequency ablation in the treatment of intrahepatic recurrent hepatocellular carcinoma. J Surg Oncol. 2023.

    Article  PubMed  Google Scholar 

  21. Zhang H, Li Q, Liu X, Zhao Z, He H, Sun F, et al. Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof-of-principle trial. J Clin Hypertens (Greenwich). 2020;22(9):1618-26.

    Article  Google Scholar 

  22. Zhao Z, Liu X, Zhang H, Li Q, He H, Yan Z, et al. Catheter-Based Adrenal Ablation Remits Primary Aldosteronism: A Randomized Medication-Controlled Trial. Circulation. 2021;144(7):580-2.

    Article  PubMed  Google Scholar 

  23. Charoensri S, Turcu AF. Primary Aldosteronism Prevalence - An Unfolding Story. Exp Clin Endocrinol Diabetes. 2023;131(7-08):394-401.

    PubMed  Google Scholar 

  24. Cook DA, Reed DA. Appraising the quality of medical education research methods: the Medical Education Research Study Quality Instrument and the Newcastle-Ottawa Scale-Education. Acad Med. 2015;90(8):1067-76.

    Article  PubMed  Google Scholar 

  25. Yang MH, Tyan YS, Huang YH, Wang SC, Chen SL. Comparison of radiofrequency ablation versus laparoscopic adrenalectomy for benign aldosterone-producing adenoma. Radiol Med. 2016;121(10):811-9.

    Article  PubMed  Google Scholar 

  26. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(5):1889-916.

    Article  CAS  PubMed  Google Scholar 

  27. Gumbs AA, Gagner M. Laparoscopic adrenalectomy. Best Pract Res Clin Endocrinol Metab. 2006;20(3):483-99.

    Article  PubMed  Google Scholar 

  28. Fu YF, Cao C, Shi YB, Zhang W, Huang YY. Computed tomography-guided cryoablation for functional adrenal aldosteronoma. Minim Invasive Ther Allied Technol. 2021;30(3):169-73.

    Article  PubMed  Google Scholar 

  29. Lo CH, Tyan YS, Ueng KC. Immediate Results and Long-Term Outcomes Following Percutaneous Radiofrequency Ablation of Unilateral Aldosterone-Producing Adenoma. Acta Cardiol Sin. 2020;36(2):160-7.

    PubMed  PubMed Central  Google Scholar 

  30. Nunes TF, Szejnfeld D, Xavier AC, Kater CE, Freire F, Ribeiro CA, et al. Percutaneous ablation of functioning adrenal adenoma: a report on 11 cases and a review of the literature. Abdom Imaging. 2013;38(5):1130-5.

    Article  PubMed  Google Scholar 

  31. Chen J, Wu J, Zhu R, Lu L, Ma XJ. Ablation versus laparoscopic adrenalectomy for the treatment of aldosterone‑producing adenoma: a meta-analysis. Abdom Radiol (NY). 2021;46(6):2795-804.

    Article  Google Scholar 

  32. Guo RQ, Li YM, Li XG. Comparison of the radiofrequency ablation versus laparoscopic adrenalectomy for aldosterone-producing adenoma: a meta-analysis of perioperative outcomes and safety. Updates Surg. 2021;73(4):1477-85.

    Article  PubMed  Google Scholar 

  33. Liu SY, Chu CM, Kong AP, Wong SK, Chiu PW, Chow FC, et al. Radiofrequency ablation compared with laparoscopic adrenalectomy for aldosterone-producing adenoma. Br J Surg. 2016;103(11):1476-86.

    Article  CAS  PubMed  Google Scholar 

  34. Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens. 2020;38(10):1919-28.

    Article  CAS  PubMed  Google Scholar 

  35. Yang R, Xu L, Lian H, Gan W, Guo H. Retroperitoneoscopic-guided cool-tip radiofrequency ablation of adrenocortical aldosteronoma. J Endourol. 2014;28(10):1208-14.

    Article  PubMed  Google Scholar 

  36. Sarwar A, Brook OR, Vaidya A, Sacks AC, Sacks BA, Goldberg SN, et al. Clinical Outcomes following Percutaneous Radiofrequency Ablation of Unilateral Aldosterone-Producing Adenoma: Comparison with Adrenalectomy. J Vasc Interv Radiol. 2016;27(7):961-7.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Mendiratta-Lala M, Brennan DD, Brook OR, Faintuch S, Mowschenson PM, Sheiman RG, et al. Efficacy of radiofrequency ablation in the treatment of small functional adrenal neoplasms. Radiology. 2011;258(1):308-16.

    Article  PubMed  Google Scholar 

  38. Cano-Valderrama O, González-Nieto J, Abad-Cardiel M, Ochagavía S, Rünkle I, Méndez JV, et al. Laparoscopic adrenalectomy vs. radiofrequency ablation for the treatment of primary aldosteronism. A single center retrospective cohort analysis adjusted with propensity score. Surg Endosc. 2022;36(3):1970-8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to express my gratitude to all those who facilitated with the writing of this manuscript. In addition, thank you to all peer reviewers for their opinions and suggestions.

Funding

This research was supported by the Natural Science Foundation of Gansu Province (21JR1RA130); Science and Technology Program of Lanzhou City (2021-1-77, 2023-2-111); the Innovation Fund of the Gansu Provincial Department of Education (2021B-047), and Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital (CY2020-BJ01).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xin Lin.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Patient and public involvement

Patients and/or the public were not involved in any stage of the research.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, R., Chen, G., Wei, T. et al. Efficacy and safety of radiofrequency ablation and laparoscopic adrenalectomy for primary aldosteronism: a meta‑analysis. Abdom Radiol (2024). https://doi.org/10.1007/s00261-024-04297-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00261-024-04297-6

Keywords

Navigation